Acadian Asset Management
TBIO

Acadian Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Acadian Asset Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-786
Closed -$22K – 2145
2021
Q2 		$22K Sell
786
-39,132
-98% -$769K ﹤0.01% 1935
2021
Q1 		$658K Sell
39,918
-76,271
-66% -$1.74M ﹤0.01% 1096
2020
Q4 		$2.14M Buy
+116,189
New +$2.08M 0.01% 739

Acadian Asset Management's TBIO Position: Q3 2021 in Review

Acadian Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 786 shares — an estimated $22K sold.

Acadian Asset Management first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $2.14M in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Acadian Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 786 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $22K.
  • Acadian Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Acadian Asset Management's Translate Bio, Inc. Common Stock position peaked at $2.14M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.